Table 1 Patient characteristics.
All (n = 94) | Study group (n = 54) | Add-on anticoagulation (n = 40) | p-value | |
|---|---|---|---|---|
Age, years | 57.6 ± 10.9 | 58.2 ± 9.8 | 56.9 ± 12.3 | n.s |
Sex (male), n (%) | 67 (71.3) | 35 (64.8) | 32 (80.0) | n.s |
Indication * | n.s | |||
Therapy refractory ascites | 64 | 35 | 29 | |
Gastrointestinal varices | 40 | 18 | 22 | |
Acute portal vein thrombosis (No flow on the main branch) | 4 | 0 | 4 | |
Others, e.g., Budd Chiari syndrome | 6 | 1 | 5 | |
TIPS location | n.s | |||
Right hepatic vein to portal vein, n | 75 | 44 | 31 | |
Middle hepatic vein to portal vein, n | 17 | 10 | 7 | |
Left hepatic vein to portal vein, n | 2 | 0 | 2 | |
Preinterventional laboratory results | ||||
Total bilirubin (mg/dl) | 1.5 ± 1.1 | 1.6 ± 1.2 | 1.3 ± 0.8 | n.s |
Serum creatinine (mg/dl) | 1.2 ± 1.0 | 1.4 ± 1.3 | 1.0 ± 0.4 | 0.022 |
Prothrombin time (s) | 40.5 ± 8.1 | 41.1 ± 8.6 | 39.6 ± 7.3 | n.s |
INR | 1.3 ± 0.2 | 1.4 ± 0.3 | 1.3 ± 0.2 | n.s |
Model for end-stage liver disease (MELD) score | 13.7 ± 4.3 | 13.8 ± 4.6 | 11.3 ± 3.4 | n.s |
Preinterventional pressure gradient (mmHg) | 15.3 ± 5.1 | 15.7 ± 5.1 | 14.7 ± 5.1 | n.s |
Postinterventional pressure gradient (mmHg) | 6.9 ± 2.6 | 6.9 ± 2.1 | 7.1 ± 3.1 | n.s |